GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (WBO:FME) » Definitions » 3-Year EPS without NRI Growth Rate

Fresenius Medical Care AG (WBO:FME) 3-Year EPS without NRI Growth Rate : -17.10% (As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Fresenius Medical Care AG 3-Year EPS without NRI Growth Rate?

Fresenius Medical Care AG's EPS without NRI for the three months ended in Sep. 2024 was €0.73.

During the past 12 months, Fresenius Medical Care AG's average EPS without NRI Growth Rate was 71.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was -17.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -12.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was -0.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Fresenius Medical Care AG was 165.70% per year. The lowest was -17.10% per year. And the median was 8.55% per year.


Competitive Comparison of Fresenius Medical Care AG's 3-Year EPS without NRI Growth Rate

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG's 3-Year EPS without NRI Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's 3-Year EPS without NRI Growth Rate falls into.



Fresenius Medical Care AG 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Fresenius Medical Care AG  (WBO:FME) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Fresenius Medical Care AG 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius Medical Care AG Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating over 300,000 patients from roughly 3,750 clinics across the globe as of mid-2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%.

Fresenius Medical Care AG Headlines

No Headlines